Non-obstructive azoospermia (NOA) is a complex, multifactorial disease. Recent genome-wide association studies (GWAS) have identified eight NOA susceptibility loci at genome-wide significance of P , 5.0 3 10 À8 in Han Chinese from southeastern, northern, and central China. To better understand the role of the variants in conferring NOA risk, we selected four GWAS loci (HLA-DRA rs3129878, PRMT6 rs12097821, SOX5 rs10842262, and PEX10 rs2477686) that were reported before 2014 to investigate their association with NOA and their potential effects on sperm production in 1177 Han males from southwest China, including 545 patients with idiopathic NOA and 632 controls with normozoospermia. The results confirmed that the HLA-DRA rs3129878 was an NOA susceptibility locus in the present population. Along with our data, meta-analyses supported the association of the four GWAS-linked loci with NOA, whereas an additive effect of the four loci on NOA susceptibility was not found. Interestingly, the normozoospermic males with the risk genotypes of rs12097821 and rs3129878 + rs10842262 + rs12097821 were observed to have higher total sperm counts relative to non-risk genotypes, suggesting that the risk alleles of the genetic loci may not be via impairing spermatogenic ability to express susceptibility to NOA. These findings may advance our understanding of the role of the NOA susceptibility loci, although the results need to be confirmed in larger samples.
INTRODUCTION
Spermatogenesis is a programed cell differentiation process that involves approximately 4% of the genes in mammalian genomes [1] . Damage to any link in the pathway may cause male infertility [2] . In humans, azoospermia accounts for 10%-15% of male infertility patients [3] [4] [5] , 50%-60% of whom have non-obstructive azoospermia (NOA), which is characterized by the absence of sperm in the ejaculate without obstruction of the reproductive tract pathway [6] . NOA occurs in approximately 1% of adult men [3] , and approximately 20%-25% of NOA cases are caused by known genetic abnormalities [7] . Of these patients, Klinefelter syndrome and Y-chromosome microdeletions are observed in approximately 10% [8, 9] . In addition, rare pretesticular genetic causes and other genetic testicular disorders that primarily affect spermatogenesis and androgen production or action can also result in NOA, including hypothalamic and pituitary disorders, chromosomal abnormalities, and certain single-gene disorders [10] [11] [12] [13] [14] [15] [16] [17] . However, a significant proportion of NOA patients have unknown etiology.
Recently, three genome-wide association studies (GWAS) in Han Chinese populations comprehensively investigated NOA-related genetic variants in the entire human genome. A total of eight genetic loci were revealed as susceptibility loci for NOA, including HLA-DRA rs3129878 and rs7194, C6 or f10/BTNL2 rs498422, PRMT6 rs12097821, PEX10 rs2477686, SOX5 rs10842262, CDC42BPA rs3000811, MIR133B-L17A rs13206743, and ABLIM1 rs7099208 [18] [19] [20] . Of these loci, the association of HLA with NOA was supported by three studies in Japanese populations [21] [22] [23] , and SOX5 rs10842262 was associated with NOA in a replicated patientcontrol study in a Han Chinese population [24] . These findings suggest that further understanding of the pathophysiology of NOA is possible. However, the reproducibility of some NOA susceptibility loci is relatively low among association studies, which strengthens the need for replicated studies in different populations to further validate NOA-related genetic variants. Additionally, limited subsequent studies have investigated the potential functional pathways that cause the loci to confer susceptibility to NOA [20] . Some basic questions remain to be clarified, such as whether an additive effect of the NOA susceptibility loci exists and whether expression of the NOA susceptibility loci impairs spermatogenesis efficiency in the general male population.
To advance our understanding of the role of the GWASlinked loci in conferring NOA susceptibility, we selected four susceptibility loci reported before 2014-HLA-DRA rs3129878, PRMT6 rs12097821, SOX5 rs10842262, and PEX10 rs2477686-that had a genome-wide significance of P , 5.0 3 10 À8 in a Han Chinese population from southeastern, northern, and central China (see Supplemental Table S1 ; Supplemental Data are available online at www. biolreprod.org) to investigate their associations with NOA in a Han Chinese population from southwest China. Moreover, their additive effect on NOA risk was analyzed. To our knowledge, this study is the first comparison of sperm production, including sperm concentration and total sperm count, between normozoospermic males with the risk and nonrisk genotypes of the loci.
MATERIALS AND METHODS

Study Samples
The present study was approved by the Ethical Review Board of West China Hospital of Sichuan University. Informed consent was obtained from all subjects. Between 2006 and 2013, a total of 1177 Han males from southwest China, including 545 unrelated patients with idiopathic NOA and 632 controls with normal spermatogenesis, were recruited from the Department of Medical Genetics and the Department of Urology, West China Hospital; the Reproductive Medicine Centre, West China Second Hospital, Sichuan University; and the Chengdu Reproductive Medicine Institute in Chengdu Women's and Children's Central Hospital. All NOA patients with some known cause of azoospermia, including chromosomal abnormality, Y-chromosome microdeletion, hypogonadotrophic hypogonadism, cryptorchidism, varicocele, seminal ductal obstruction, testicular trauma, and tumor were excluded via karyotype testing, AZF deletion screening, hormone analysis, scrotal ultrasound, and physical examination. The subjects with two potential negative factors for spermatogenesis, including partial AZFc deletions and duplications [25] [26] [27] [28] [29] , were also excluded. All of the subjects underwent a minimum of two semen analyses; the sperm of the NOA patients was not detected in the ejaculate after centrifugation. The controls had normal sperm production, motility, and morphology as defined according to World Health Organization criteria [30] .
Genotyping of GWAS-Linked NOA Susceptibility Loci
Genomic DNA was extracted from peripheral blood lymphocytes using a DNA purification kit (Tiangen Biotech Co., Ltd.). The DNA concentration was determined using a NanoDrop 1000 spectrophotometer (GE Healthcare), and the DNA was gradually diluted to approximately 50 ng/ll for PCR assays.
Genotyping of the four single-nucleotide polymorphism (SNP) loci was performed using Applied Biosystems TaqMan SNP Genotyping Assays kits for HLA-DRA rs3129878 (A/C; clone code 27462276), PRMT6 rs12097821 (G/T; clone code 31905167), SOX5 rs10842262 (C/G; clone code 31383398), and PEX10 rs2477686 (C/G; clone code: 1975065). Briefly, PCR amplification was performed in 5 ll of buffered solution containing 10 ng of genomic DNA, 2.5 ll of Genotyping Master Mix, and 0.25 ll of assay mix on a 384-well reaction plate. The reaction procedure was as follows: predenaturing at 958C for 10 min, followed by 40 cycles of 958C for 15 sec and 608C for 1 min. The genotyping data were collected and analyzed by an ABI 7900 instrument (Invitrogen). Negative, positive, and duplicate controls were included in each 384-well assay. Of the 1177 samples, 30% were subjected to Sanger sequencing of the PCR products to confirm their genotypes. The genotypes of the samples detected by the two methods were completely concordant.
Statistical Analysis
Hardy-Weinberg equilibrium testing was performed for each SNP using the Pearson chi-square test in SNPAlyze 6.0 (Dynacom Co., Ltd.). The allele frequencies were compared between the patients with NOA and controls with normozoospermia using a chi-square test in SPSS 17.0 (SPSS, Inc.). Moreover, the Cochran-Armitage trend tests of the genotype frequencies were conducted between patients and controls in SAS 9.1.3 (SAS Institute, Inc.). The metaanalyses for the NOA susceptibility of SNPs were performed by combining our data and previously reported data from the other cohorts using Stata 12.0 (StataCorp).
The risk allele nature of the loci was presumed according to the results of single-variable logistic regression to distinguish additive, dominant, or recessive models, in which the inheritance model of HLA-DRA rs3129878 was analyzed using our data and the remaining three loci were analyzed using our data and previously reported data [18, 19, 23, 24, 31] . After distinguishing the risk and non-risk genotypes of the loci based on their inheritance models, the combined effects of the multiple loci were analyzed using a multivariable logistic regression method. The logistic regression analyses were performed using SPSS 17.0.
The correlation between the risk genotypes of SNPs and sperm production, including sperm concentration and total sperm count, were investigated using a non-parametric median test in SPSS 17.0, accounting for the fact that the sperm production was not evenly distributed among the subjects. For the two-sided Mann-Whitney tests, P , 0.05 was considered to be statistically significant; for the chi square tests, the statistical significance levels were corrected with the Bonferroni method for multiple tests.
Statistical Power Analysis
Considering that differences in the allele and genotype distribution of rs12097821, rs10842262, and rs2477686 were not observed between the NOA patients and controls in the present study, we performed a statistical power analysis with the Genetic Power Calculator (http://pngu.mgh.harvard.edu/ ;purcell/gpc/). The tests were defaulted at a type I error rate of 0.05, and the risk allele frequencies of rs12097821, rs10842262, and rs2477686 in the population were inferred from previously reported GWAS data [19] .
RESULTS
Association of SNPs with NOA Susceptibility
Four GWAS-linked susceptibility SNPs were genotyped in 1177 Han subjects (545 patients with NOA and 632 controls with normozoospermia). Their genotype distributions in patients and controls were in Hardy-Weinberg equilibrium (P . 0.05) (see Supplemental Table S1 ). Allele and genotype frequency comparisons of the four SNPs between patients and controls are summarized in Table 1 . Of these SNPs, the allele distribution of HLA-DRA rs3129878 was significantly different between patients and controls, with the risk allele C more common in the patients (P ¼ 1.23 3 10 À6 ). The results of the trend test also supported that risk allele C of HLA-DRA rs3129878 significantly affected NOA susceptibility (P ¼ 7.13 3 10 À6 ). However, significant associations between the remaining three SNPs and NOA were not observed in the present population. Considering the low statistical power of the present study at 60.8%, 56.2%, and 65.4% for PRMT6 rs12097821, SOX5 rs10842262, and PEX10 rs2477686, respectively, the influence of the loci on NOA risk cannot be excluded. To clarify the effects of these SNPs, we performed meta-analyses to evaluate the overall associations of the loci risk alleles with NOA susceptibility by combining the data of the present study and with that of previous reports [18, 19, 23, 24, 31] . Significant associations were observed in the metaanalyses (meta-analysis, a ¼ 0.05; PRMT6 rs12097821: OR ¼ 1.16, 95% CI ¼ 1.05-1.28, P ¼ 0.004; SOX5 rs10842262: OR ¼ 1.22, 95% CI ¼ 1.15-1.29, P , 0.001; PEX10 rs2477686: OR ¼ 1.28, 95% CI ¼ 1.13-1.46, P , 0.001) (Fig. 1, A-C) . In addition, the association of the risk allele of HLA-DRA rs3129878 with NOA was further confirmed (meta-analysis with a random effect model, a ¼ 0.05; OR ¼ 1.40, 95% CI ¼ 1.25-1.58, P , 0.001) (Fig. 1D) .
To obtain evidence for the association of the loci with NOA at the genotype level, the potential inheritance models of loci risk alleles were further deduced using a single-variable logistic regression method. The results demonstrated that the risk allele C of HLA-DRA rs3129878 was more likely to be additive (single-variable logistic regression analysis, a 0 ¼ 0.05/12 ¼ 0.004 with Bonferroni correction; additive model P ¼ 9.78 3 10 À6 ) (see Supplemental Table S2 ). The P-values of PRMT6 rs12097821, PEX10 rs2477686, and SOX5 rs10842262 did not reach significance in the inheritance model analyses of the risk alleles using our data. Therefore, we repeated the singlevariable logistic regression analysis of the three SNPs using the combined data of the present study and previous reports [18, 19, 23, 24, 31] . The results indicated that the inheritance models of the risk alleles of PRMT6 rs12097821 and PEX10 rs2477686 were more likely to be additive (single-variable Table S2 ). Based on the above results, the risk genotype of each locus was distinguished from the non-risk genotype, and then the associations of the loci risk genotypes with NOA risk were further analyzed using a conditional multivariable logistic regression analysis of the four SNPs. As shown in Table 2 , a significant risk of NOA susceptibility was observed for the HLA-DRA rs3129878 genotype (multivariable logistic regression analysis, a 0 ¼ 0.05/4 ¼ 0.013 with Bonferroni correction; rs3129878: P ¼ 0.001). Meta-analyses for the loci risk genotypes were performed, and the results further confirmed the effect of the loci on NOA risk at the genotype level (see Supplemental Figure S1 ) [18, 19, 23, 24, 31] .
Furthermore, we performed an association analysis to explore the compound effect of the multilocus models using a conditional multivariable logistic regression method. For   FIG. 1 . Meta-analyses for the overall associations of the risk alleles of the GWAS loci with NOA susceptibility. An asterisk indicates data from the present study. A) For PRMT6 rs12097821, the risk allele T was more common in patients with NOA. B) For SOX5 rs10842262, the risk allele G was more common in patients with NOA. C) For PEX10 rs2477686, the risk allele G was more common in patients with NOA. D) For HLA-DRA rs3129878, the risk allele C was more common in patients with NOA. NOA SUSCEPTIBILITY LOCI AND SPERM PRODUCTION each two-locus combination (SNP1 þ SNP2), we performed three regression analyses with a different observed variable (SNP1, SNP2, or SNP1 þ SNP2) and two common reference variables (SNP3/SNP4) in each analysis to compare the effects of the observed variables on NOA in the same background. Similarly, for each three-locus combination (SNP1 þ SNP2 þ SNP3), four regression analyses were performed with a different observed variable
) and a common reference variable (SNP4). However, no multilocus model had a significant effect on NOA risk (see Supplemental Tables S3  and S4 ).
Correlation Between SNPs and Sperm Production in Males with Normozoospermia
To investigate the potential effect of the GWAS-linked loci on spermatogenesis efficiency, we analyzed the correlation between the SNPs and sperm production by comparing sperm concentrations and total sperm counts between normozoospermic males with the risk and non-risk genotypes. Initially, we compared the average ages between the risk and non-risk groups to exclude age bias from the analyses (see Supplemental Tables S5). Interestingly, the risk genotype of PRMT6 rs12097821 was associated with increased total sperm number (Mann-Whitney test, a ¼ 0.025; P ¼ 0.014). In addition, for all four loci, males with risk genotypes had relatively high sperm production compared with non-risk genotypes, although the difference was not statistically significant (Table 3) .
Furthermore, we investigated the effects of the multilocus models on sperm production by comparing sperm concentrations and total sperm counts between normozoospermic males with combined risk and non-risk genotypes in the loci. The results determined that the combined risk genotype of the three-locus combination rs3129878 þ rs10842262 þ rs12097821 was associated with increased total sperm number (Mann-Whitney test, a 0 ¼ 0.025; rs3129878 þ rs10842262 þ rs12097821: P ¼ 0.018) ( Table 4) .
DISCUSSION
In the present study, we confirmed the significant association of HLA-DRA rs3129878 with NOA susceptibility at the allele and genotype levels, which was further supported by the results of a meta-analysis combining the data of the present and previous studies [18, 23] . Before the publication of the NOA GWAS, two candidate gene-based studies had suggested the association of HLA-DRB1 with NOA in Japanese populations [21, 22] . Recently, two GWAS further identified the influence of HLA-DRA on NOA risk in Han Chinese populations, which was repeated in a Japanese cohort [18, 20, 23] . These findings strongly suggest that the HLA region is involved in NOA etiology; additionally, it may be a common and critical NOA susceptibility locus in different populations, considering that this locus had the most significant association with NOA susceptibility in all relevant studies [18, 20, 23] . This further indicates the prominent contribution of immune factors in individual NOA susceptibility. HLA antigens have been associated with NOA susceptibility [32, 33] , and inflammation-related genes have been identified that are involved in spermatogenic failure [22, 23, 34] . Therefore, it is reasonable to speculate that the NOA susceptibility mediated Table 2 . c Mann-Whitney test for the difference in sperm concentration between males with the risk and non-risk genotypes; the significance level was corrected with the formula of a 0 ¼ a/2 ¼ 0.025 according to the Bonferroni method. d Mann-Whitney test for the difference in total sperm count between males with the risk and non-risk genotypes; the significance level was corrected with the formula of a 0 ¼ a/2 ¼ 0.025 according to the Bonferroni method. e P-values showing a significant difference are in bold. In the comparisons, the average age was similar between males with the non-risk and risk genotype (see Supplemental Table 5S ).
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by HLA is due to effects on the inflammation process of testicular tissues, which increase the risk for interrupting spermatogenesis [18] . However, further detailed evidence is necessary to explore the role of the HLA region in NOA etiology.
For PRMT6 rs12097821, SOX5 rs10842262, and PEX10 rs2477686, we did not observe any association with NOA risk. In other replication studies previously reported, the effects of the three GWAS loci on NOA susceptibility were also not consistently repeated [24, 31] . However, the contribution of the loci to NOA susceptibility should not be excluded due to the relatively low statistical power in the studies; this is supported by the results of our meta-analysis. Considering the minor effect of each single locus on NOA susceptibility, we initially analyzed for the presence of additive effects of the four GWAS loci on NOA susceptibility using multilocus models of risk genotypes as defined by their potential inheritance models. However, we found no evidence for their compound effect on NOA susceptibility risk. Specifically, an association of the multilocus model that included HLA-DRA rs3129878 was not observed, although the latter was significantly associated with NOA susceptibility in the single-locus analysis. These findings imply that the pathways conferring NOA susceptibility risk in males may be distinct among the susceptibility loci.
A complex, multifactorial disease, NOA is the most severe form of spermatogenesis failure. In theory, NOA onset in males likely is due to a crucial insult from unknown negative environmental factors or functional genome mutations based on the individual variation in NOA susceptibility that certain genetic variants possess. We should not exclude the possibility that some variants influence NOA susceptibility by affecting sperm production. Recently, a GWAS identified several genetic loci that were associated with sperm concentration and/or total sperm count [35] . Consequently, we further investigated the correlation between the four NOA susceptibility loci and sperm productions in males with normozoospermia, considering that the loci may be directly or indirectly involved in spermatogenesis [18, 19] . Surprisingly, increased total sperm counts were observed in males with the risk (combined) genotype of PRMT6 rs12097821, and rs3129878 þ rs10842262 þ rs12097821 relative to the non-risk genotype. Although these results need to be confirmed in larger samples, they are reasonable. For example, HLA-DRA rs3129878 is associated with NOA risk in both Han Chinese and Japanese populations, suggesting that in these two populations there may be certain unknown common genetic variations that produce NOA susceptibility that are linked to the rs3129878 risk allele, if it is not a functional SNP. However, it is unknown why a risk allele-linked variant that increases NOA risk maintains a relatively high frequency in populations after several generations if the variant can be traced to the separation of the two populations. Therefore, the NOA susceptibility variants may also have other pathway effects that compensate for impaired reproductive fitness. Although direct evidence for this phenomenon is absent, we speculate that the NOA susceptibility variants may affect two or more pathways, one of which confers NOA susceptibility and another that up-regulates sperm production. The compound effect of the loci on male reproduction maintains the high-frequency presence of the risk alleles in populations.
In conclusion, the present study further confirms that HLA-DRA rs3129878 is an outstanding NOA susceptibility locus among the GWAS-identified loci. Additionally, the metaanalyses strongly support the association of HLA-DRA rs3129878, PRMT6 rs12097821, SOX5 rs10842262, and PEX10 rs2477686 with NOA. However, the additive effect of the four loci on NOA risk is absent, suggesting their effects on the pathways that confer NOA risk may be different. To our knowledge, this is the first time that increased total sperm counts were observed in normozoospermic males with two NOA risk genotypes in single-or multilocus models relative to non-risk genotypes, which provides new insights regarding the Mann-Whitney test for the difference in total sperm count between males with the combined risk and non-risk genotypes; the significance level was corrected with the formula of a 0 ¼ a/2 ¼ 0.025 according to the Bonferroni method. f P-values showing a significant difference are in bold. In the comparisons, the average age was similar between males with the combined non-risk and risk genotype (see Supplemental Table 5S ).
NOA SUSCEPTIBILITY LOCI AND SPERM PRODUCTION contribution of the NOA susceptibility loci to male reproduction fitness.
